Elanco Animal Health Executive Compensation Details
Ticker: ELAN · Form: DEF 14A · Filed: Mar 27, 2025 · CIK: 1739104
| Field | Detail |
|---|---|
| Company | Elanco Animal Health Inc (ELAN) |
| Form Type | DEF 14A |
| Filed Date | Mar 27, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: executive-compensation, proxy-statement, equity-awards
TL;DR
Elanco's 2025 DEF 14A is out, showing exec comp details for 2024. Focus on equity awards for PEOs and non-PEOs.
AI Summary
Elanco Animal Health Inc. filed its DEF 14A on March 27, 2025, detailing executive compensation for the fiscal year ending December 31, 2024. The filing includes information on equity awards granted to both principal executive officers (PEO) and non-PEO/NEO members, as well as changes in the fair value of outstanding and unvested equity awards.
Why It Matters
This filing provides transparency into how Elanco Animal Health compensates its top executives, which can influence investor perception and corporate governance.
Risk Assessment
Risk Level: low — This is a routine annual filing providing information on executive compensation and does not indicate any immediate financial distress or significant operational changes.
Key Numbers
- 2024 — Fiscal Year (Compensation details are for this year.)
- 20250327 — Filing Date (Date the DEF 14A was submitted to the SEC.)
Key Players & Entities
- Elanco Animal Health Inc (company) — Filer of the DEF 14A
- 2024-12-31 (date) — Fiscal year end for compensation details
- 20250327 (date) — Filing date of the DEF 14A
FAQ
What is the primary purpose of a DEF 14A filing?
A DEF 14A filing, also known as a Definitive Proxy Statement, is used to solicit proxies from shareholders for an upcoming annual meeting or special meeting of shareholders. It contains detailed information about matters to be voted on, including director elections, executive compensation, and other corporate governance issues.
Who are the Principal Executive Officers (PEO) and Non-PEO/NEO members mentioned in the filing?
The filing refers to equity awards granted to 'PeoMember' (Principal Executive Officer members) and 'NonPeoNeoMember' (Non-Principal Executive Officer/Named Executive Officer members), indicating compensation structures for different tiers of company leadership.
What specific types of equity awards are detailed in the filing?
The filing details 'EqtyAwrdsInSummryCompstnTblForAplblYrMember' (Equity Awards in Summary Compensation Table for Applicable Year Member), 'YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember' (Year-End Fair Value of Equity Awards Granted in Covered Year Outstanding and Unvested Member), and 'ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember' (Change in Fair Value of Outstanding and Unvested Equity Awards Granted in Prior Years Member).
What is the significance of the 'ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember' metric?
This metric refers to the change in the fair value as of the vesting date of prior year equity awards that vested in the covered year, providing insight into the performance of previously granted awards.
When is Elanco Animal Health's fiscal year end?
Elanco Animal Health's fiscal year ends on December 31st, as indicated by the reporting periods for which compensation data is presented.
Filing Details
This Form DEF 14A (Form DEF 14A) was filed with the SEC on March 27, 2025 regarding Elanco Animal Health Inc (ELAN).